What is NDC 55111-533?

55111-533 is the product NDC for Divalproex Sodium, Divalproex sodium 250 mg/1 tablet, film coated, extended release, listed with the FDA by Dr. Reddy's Laboratories Ltd. It has 5 package NDCs, shown above in 10- and 11-digit form.

Dr. Reddy's Laboratories Ltd, NDC labeler code 55111. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Divalproex Sodium?

185 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Divalproex Sodium NDC 55111-533 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)55111-533Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55111-0533Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
55111-533-01	5511105330155111053301	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55111-533-01)Marketed from Aug 11, 2013
55111-533-05	5511105330555111053305	500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55111-533-05)Marketed from Aug 11, 2013
55111-533-30	5511105333055111053330	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55111-533-30)Marketed from Aug 11, 2013
55111-533-60	5511105336055111053360	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (55111-533-60)Marketed from Aug 11, 2013
55111-533-78	5511105337855111053378	10 BLISTER PACK in 1 CARTON (55111-533-78) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (55111-533-79)Marketed from Aug 11, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Divalproex Sodium
Generic name (nonproprietary): divalproex sodium
Active ingredients: Divalproex sodium — 250 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Dr. Reddy's Laboratories LtdNDC labeler code 55111
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090161
Marketing start: Aug 11, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 55111-533_86498fa3-61af-c27e-9f94-b2a3fb6e16dfSPL ID 86498fa3-61af-c27e-9f94-b2a3fb6e16dfSPL set ID 2e35f833-1cf7-12eb-9567-7a191e32e138RxCUI 1099563UNII 644VL95AO6
Pharmacologic class: Anti-epileptic Agent; Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455111053301 followed by a unit qualifier and the quantity

Package 55111-0533-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 7, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Divalproex sodium extended-release tablet is indicated for: Acute treatment of manic or mixed episodes associated with bipolar disorder, with or without psychotic features (1.1) Monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures (1.2) Prophylaxis of migraine headaches (1.3) 1.1 Mania Divalproex sodium extended-release tablet is a valproate and is indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, with or without psychotic features. A manic episode is a distinct period of abnormally and persistently elevated, …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 55111-533

What is NDC 55111-533?: 55111-533 is the product NDC for Divalproex Sodium, Divalproex sodium 250 mg/1 tablet, film coated, extended release, listed with the FDA by Dr. Reddy's Laboratories Ltd. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Divalproex Sodium.
What is the active ingredient?: Divalproex sodium.
Who is the labeler?: Dr. Reddy's Laboratories Ltd, NDC labeler code 55111. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Divalproex Sodium?: 185 other product NDCs are listed under this name. See all Divalproex Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Divalproex Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
divalproex sodium	Divalproex sodium 250 mg/1	Tablet, Film coated, Extended releaseOral	Coupler LLC	67046-1696	67046-1696-03
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Delayed releaseOral	Cardinal Health 107, LLC	55154-0577	55154-0577-00
divalproex sodium	Divalproex sodium 500 mg/1	Tablet, Film coated, Extended releaseOral	Preferred Pharmaceuticals Inc.	68788-4193	68788-4193-0368788-4193-0668788-4193-09
divalproex sodium	Divalproex sodium 250 mg/1	Tablet, Delayed releaseOral	Coupler LLC	67046-1683	67046-1683-03
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Delayed releaseOral	Unit Dose Solutions, Inc.	87441-027	87441-0027-01
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Delayed releaseOral	Unit Dose Solutions, Inc.	87441-028	87441-0028-01
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-2021	67046-2021-03
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Extended releaseOral	Preferred Pharmaceuticals Inc.	68788-4100	68788-4100-0368788-4100-0668788-4100-09
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Film coated, Extended releaseOral	Safecor Health, LLC	48433-033	48433-0033-08
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Film coated, Extended releaseOral	Safecor Health, LLC	48433-034	48433-0034-08

All 186 Divalproex Sodium NDCs

Other NDCs under ANDA 090161

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090161
Product	Strength	Form · route	Labeler	Product NDC
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Film coated, Extended releaseOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8329
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Film coated, Extended releaseOral	Major Pharmaceuticals	0904-6363
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-2021
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-1138